The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management
Sign Up to like & getrecommendations! Published in 2025 at "Current Cardiovascular Risk Reports"
DOI: 10.1007/s12170-025-00761-0
Abstract: Obesity pharmacotherapy is rapidly evolving with the ability of glucagon-like peptide- 1 receptor agonists (GLP-1RAs) to improve atherosclerotic cardiovascular disease (ASCVD) outcomes. This review focuses on how GLP-1RAs impact lipid-related outcomes. Beyond weight reduction, GLP-1RAs… read more here.
Keywords: glp 1ra; 1ra medications; reduction; role glp ... See more keywords
The role of GLP-1 receptor agonists in managing type 2 diabetes
Sign Up to like & getrecommendations! Published in 2022 at "Cleveland Clinic Journal of Medicine"
DOI: 10.3949/ccjm.89a.21110
Abstract: Glucagon-like peptide-1 (GLP-1) receptor agonists improve glycemic control in patients with type 2 diabetes mellitus, have cardioprotective and renoprotective effects, and do not cause weight gain or significant hypoglycemia. In fact, they have been found… read more here.
Keywords: receptor agonists; glp receptor; type diabetes; role glp ... See more keywords